59 related articles for article (PubMed ID: 2778378)
1. [Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal cancer patients].
Koyama H; Narisawa T; Kodama M; Ishikawa K; Kusaka H; Yamazaki Y; Koyama K
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1027-33. PubMed ID: 2778378
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin].
Narisawa T; Takahashi M; Masuda T; Nagasawa O; Koyama H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2496-501. PubMed ID: 3476022
[TBL] [Abstract][Full Text] [Related]
4. [Anti-cancer treatment with prostaglandin synthetase inhibitor in animal models].
Narisawa T; Takahashi M; Masuda T; Nagasawa O; Ogata N; Niwa M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1329-35. PubMed ID: 3089171
[TBL] [Abstract][Full Text] [Related]
5. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
6. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation.
Markewitz A; Faist E; Lang S; Endres S; Fuchs D; Reichart B
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):15-24. PubMed ID: 8419695
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
8. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
Saarloos MN; Khoo NK; Lala PK
Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of the inhibitory effect of indomethacin on the growth and angiogenesis of human colon cancer xenografts.
Wang HM; Zhang GY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):184-7. PubMed ID: 14965822
[TBL] [Abstract][Full Text] [Related]
12. Modification of the effects of cytotoxic chemotherapy on the immune responses of cancer patients with a nonsteroidal, antiinflammatory drug, piroxicam. A pilot study of the Eastern Cooperative Oncology Group.
Braun DP; Bonomi PD; Taylor SG; Harris JE
J Biol Response Mod; 1987 Jun; 6(3):331-45. PubMed ID: 3037033
[TBL] [Abstract][Full Text] [Related]
13. Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin.
Narisawa T; Takahashi M; Niwa M; Fukaura Y; Wakizaka A
Jpn J Cancer Res; 1987 Aug; 78(8):791-8. PubMed ID: 3115924
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin induces the suppression of plasma neutral proteinase activity in mice: possible relationship to efficacy as an anti-inflammatory drug and induction of alterations in the immune system.
Hart DA
J Clin Lab Immunol; 1986 Aug; 20(4):199-205. PubMed ID: 3020255
[TBL] [Abstract][Full Text] [Related]
15. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases.
Johansson C; Kollberg B; Nordemar R; Samuelson K; Bergström S
Gastroenterology; 1980 Mar; 78(3):479-83. PubMed ID: 7351286
[TBL] [Abstract][Full Text] [Related]
19. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
Gelin J; Andersson C; Lundholm K
Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
[TBL] [Abstract][Full Text] [Related]
20. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
Chirigos MA; Schlick E; Saito T; Gruys E
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
